FindTrial
Sign In

Denosumab 60 mg/ml [Prolia]

DRUG4 trials

Sponsors

Mishaela Rubin, Ain Shams University, Shenzhen People's Hospital

Conditions

Diabetes Mellitus, Type 2Lumbar SpondylolisthesisOsteopeniaOsteoporosisOsteoporosis, OsteopeniaOsteoporotic Vertebral Compression FractureRenal Transplant Recipient

Phase 2

Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab
TerminatedNCT03457818
Mishaela RubinDiabetes Mellitus, Type 2, Osteoporosis
Start: 2018-11-07End: 2020-06-10Updated: 2024-07-03
Alendronate Versus Denosumab in Kidney Transplant Patients
CompletedNCT04169698
Ain Shams UniversityOsteoporosis, Osteopenia, Renal Transplant Recipient
Start: 2019-10-17End: 2021-05-01Updated: 2021-11-12
Denosumab and Osteoporotic Vertebral Compression Fracture
CompletedNCT05058443
Shenzhen People's HospitalOsteoporotic Vertebral Compression Fracture
Start: 2020-01-06End: 2022-08-10Updated: 2023-02-21

Phase 3

Denosumab vs Zoledronate After Lumbar Fusion
NCT05638399
Shenzhen People's HospitalLumbar Spondylolisthesis, Osteopenia
Start: 2020-01-15End: 2023-02-28Target: 100Updated: 2023-02-21

Related Papers

Evaluation of the efficacy and tolerability of alendronate versus denosumab in kidney transplant patients with reduced bone mineral density
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy2023-06-162 citations